We can't find the internet
Attempting to reconnect
Something went wrong!
Hang in there while we get back on track
£520.00
The 2023-2028 Outlook for Benzodiazepine Drugs in the United States
Price data last checked 121 day(s) ago - refreshing...
We'll watch every seller, every day. One email when your price arrives.
It has never been this cheap. We have no record of a lower price.
£520 today · cheaper than every other day in the last 11 months
NEW HERE?
Amazon shows you one price. We show you all of them.
Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.
WHAT'S ON THIS PAGE
when this has been cheap or pricey
where the price is heading next
all-time high & low, recent range
name your number, we'll email you
Price History & Forecast
Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.
Last 214 days • 214 data points (No recent data available)
Price Distribution
Price distribution over 214 days • 1 price levels
Price Analysis
Most common price: £520 (214 days, 100.0%)
Price range: £520 - £520
Price levels: 1 different prices over 214 days
Product Specifications
- Format
- Paperback
- ASIN
- B0BLQQNNZY
- Category
- Books > Subjects
- Domain
- Amazon UK
- Release Date
- 26 October 2022
- Listed Since
- 09 November 2022
Similar Products You Might Like
The 2023-2028 Outlook for Benzodiazepine Drugs in India
The 2025-2030 World Outlook for Benzodiazepine Drugs
The 2023-2028 Outlook for Benzodiazepine Drugs in Japan
The 2023-2028 Outlook for Benzodiazepine Drugs for US Zip Codes
The 2016-2021 Outlook for Prescription Non-Barbituate Anxiolytic and Hypnotic Sedatives in Japan
The 2016-2021 Outlook for Prescription Non-Barbituate Anxiolytic and Hypnotic Sedatives in the United States
The 2016 Report on Prescription Non-Barbituate Anxiolytic and Hypnotic Sedatives: World Market Segmentation by City
The 2013-2018 Outlook for Non-Prescription Anxiolytic, Hypnotic, and Sleep-Inducing Sedatives Excluding Antihistamines in India
The 2021-2026 World Outlook for Non-Prescription Anxiolytic, Hypnotic, and Sleep-Inducing Sedatives Excluding Antihistamines
The 2023-2028 Outlook for Anxiety Disorder Therapeutics in the United States
The 2023-2028 Outlook for Anxiety Disorder Treatments in the United States
The 2023-2028 Outlook for Anxiety Disorders and Depression in the United States
The 2023-2028 Outlook for Anxiety Disorders and Depression Treatments in the United States
Simultaneous Estimation of Benzodiazepines and Antidepressants: Optimization of SPE Protocol for single step and sequential elution followed by their HPLC estimation
LAP Lambert Academic Publishing
The 2023-2028 Outlook for Antidepressants for Anxiety Disorders in the United States
The 2026-2031 World Outlook for Antidepressants for Anxiety Disorders
BENZODIAZEPINE: Abuse & Therapeutic Uses, Pharmacology & Health Effects (Pharmacology - Research, Safety Testing and Regulation: Substance Abuse Assessment, Interventions and Treatment)
The 2023-2028 Outlook for Insomnia Drugs in the United States
The 2025-2030 World Outlook for Benzenoid Aroma Chemicals
The 2023-2028 Outlook for Animal Medications in the United States
The 2025-2030 World Outlook for Benzyl Alcohols
The 2023-2028 Outlook for Insomnia Therapeutics in the United States
The 2023-2028 Outlook for Bed Monitoring System and Baby Monitoring Systems in the United States
